Pfizer aims for full FDA approval of vaccine


Pfizer has started the process of seeking full approval from American regulators for its covert nineteen vaccine after getting a merchant see use authorization five months ago more than one hundred seventy million of the vaccines doses have been delivered across the US such authorization only lasts until countries declared the emergency is over so the vaccines need a more stringent review to get full approval for continued use Pfizer is started giving the FDA data from human they have the lab testing and will submit more these reviews generally take a few months is our understanding White House virus response coordinator Jeff science says the FDA will move as fast as possible without compromising safety sabar mag ani Washington

Coming up next